A detailed history of Donald Yacktman (Yacktman Asset Management LP) transactions in Johnson & Johnson stock. As of the latest transaction made, Yacktman Asset Management LP holds 1,506,840 shares of JNJ stock, worth $243 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares
1,506,840
Previous 1,514,714 0.52%
Holding current value
$243 Million
Previous $240 Million 8.09%
% of portfolio
2.18%
Previous 2.28%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$144.38 - $157.78 $1.14 Million - $1.24 Million
-7,874 Reduced 0.52%
1,506,840 $220 Million
Q1 2024

May 02, 2024

SELL
$155.22 - $162.74 $279,240 - $292,769
-1,799 Reduced 0.12%
1,514,714 $240 Million
Q4 2023

Feb 02, 2024

SELL
$145.6 - $158.88 $946,982 - $1.03 Million
-6,504 Reduced 0.43%
1,516,513 $238 Million
Q3 2023

Nov 01, 2023

SELL
$155.75 - $174.48 $74.6 Million - $83.6 Million
-478,941 Reduced 23.92%
1,523,017 $237 Million
Q2 2023

Aug 08, 2023

SELL
$154.35 - $166.11 $4.37 Million - $4.7 Million
-28,311 Reduced 1.39%
2,001,958 $331 Million
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $6.31 Million - $7.53 Million
-41,790 Reduced 2.02%
2,030,269 $315 Million
Q4 2022

Jan 26, 2023

SELL
$160.2 - $179.79 $3.03 Million - $3.41 Million
-18,939 Reduced 0.91%
2,072,059 $0
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $7.47 Million - $8.31 Million
-46,301 Reduced 2.17%
2,090,998 $342 Million
Q2 2022

Aug 04, 2022

SELL
$168.19 - $186.01 $5.04 Million - $5.57 Million
-29,951 Reduced 1.38%
2,137,299 $379 Million
Q1 2022

May 02, 2022

SELL
$158.14 - $179.59 $6.87 Million - $7.81 Million
-43,467 Reduced 1.97%
2,167,250 $384 Million
Q4 2021

Feb 02, 2022

BUY
$155.93 - $173.01 $3.78 Million - $4.2 Million
24,270 Added 1.11%
2,210,717 $378 Million
Q3 2021

Nov 01, 2021

SELL
$161.5 - $179.47 $1.07 Million - $1.19 Million
-6,635 Reduced 0.3%
2,186,447 $353 Million
Q2 2021

Aug 03, 2021

SELL
$159.48 - $171.07 $849,868 - $911,632
-5,329 Reduced 0.24%
2,193,082 $361 Million
Q1 2021

May 04, 2021

BUY
$153.07 - $170.48 $3.88 Million - $4.33 Million
25,379 Added 1.17%
2,198,411 $361 Million
Q4 2020

Feb 01, 2021

SELL
$137.11 - $157.38 $4.65 Million - $5.34 Million
-33,931 Reduced 1.54%
2,173,032 $342 Million
Q3 2020

Oct 30, 2020

BUY
$140.38 - $153.83 $5.91 Million - $6.48 Million
42,102 Added 1.94%
2,206,963 $329 Million
Q2 2020

Aug 06, 2020

SELL
$128.81 - $155.51 $97.5 Million - $118 Million
-756,771 Reduced 25.9%
2,164,861 $304 Million
Q1 2020

May 04, 2020

SELL
$111.14 - $153.99 $88.8 Million - $123 Million
-798,599 Reduced 21.47%
2,921,632 $383 Million
Q4 2019

Feb 04, 2020

SELL
$127.5 - $146.44 $114 Million - $131 Million
-896,236 Reduced 19.41%
3,720,231 $543 Million
Q3 2019

Nov 05, 2019

SELL
$126.95 - $142.14 $7.53 Million - $8.43 Million
-59,294 Reduced 1.27%
4,616,467 $597 Million
Q2 2019

Aug 02, 2019

SELL
$131.15 - $144.24 $5.78 Million - $6.35 Million
-44,045 Reduced 0.93%
4,675,761 $651 Million
Q1 2019

May 02, 2019

BUY
$125.72 - $139.79 $1.47 Million - $1.63 Million
11,692 Added 0.25%
4,719,806 $660 Million
Q4 2018

Feb 04, 2019

SELL
$122.84 - $147.84 $17 Million - $20.5 Million
-138,554 Reduced 2.86%
4,708,114 $608 Million
Q3 2018

Nov 08, 2018

SELL
$121.58 - $142.88 $34.3 Million - $40.3 Million
-282,293 Reduced 5.5%
4,846,668 $670 Million
Q2 2018

Aug 03, 2018

SELL
$119.4 - $131.76 $5.33 Million - $5.88 Million
-44,654 Reduced 0.86%
5,128,961 $622 Million
Q1 2018

May 09, 2018

SELL
$125.1 - $148.14 $1.62 Million - $1.92 Million
-12,929 Reduced 0.25%
5,173,615 $663 Million
Q4 2017

Feb 02, 2018

SELL
$131.22 - $143.62 $61.3 Million - $67.1 Million
-467,079 Reduced 8.26%
5,186,544 $725 Million
Q3 2017

Nov 03, 2017

BUY
$129.47 - $135.38 $732 Million - $765 Million
5,653,623
5,653,623 $735 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $422B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track Donald Yacktman's Portfolio

Track Donald Yacktman Portfolio

Follow Donald Yacktman (Yacktman Asset Management LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yacktman Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Yacktman Asset Management LP and Donald Yacktman with notifications on news.